Kyntra Bio: Renal Insufficiency, Chronic trials
The registry lists 10 Renal Insufficiency, Chronic studies with Kyntra Bio as lead sponsor. 0 are open to participants now and 7 have results posted.
Phase 2 4Phase 3 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Study to Evaluate the Efficacy and Safety of Roxadustat in the Treatment of Anemia in Participants With ESRD on Stable DialysisCompletedNCT02273726Phase 3Results posted
- Safety and Efficacy Study of Roxadustat (FG-4592) for the Treatment of Anemia in End-Stage Renal Disease (ESRD) Newly Initiated Dialysis ParticipantsCompletedNCT02052310Phase 3Results posted
- A Study of Roxadustat for the Treatment of Anemia in Participants With Chronic Kidney Disease and Not Receiving DialysisCompletedNCT01750190Phase 3Results posted
- Open-Label Extension Study for the Long-Term Efficacy and Safety of Roxadustat in Participants With Dialysis and Non-Dialysis Chronic Kidney DiseaseCompletedNCT01630889Phase 2Results posted
- Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With AnemiaCompletedNCT01244763Phase 2Results posted
- Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance HemodialysisCompletedNCT01147666Phase 2Results posted
- Phase 2 Study of Roxadustat in Participants With Anemia and Chronic Kidney Disease Not Requiring DialysisCompletedNCT00761657Phase 2Results posted
- Investigating the Efficacy, Safety and PK of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKDWithdrawnNCT04621331Phase 3
- FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease Not on DialysisCompletedNCT02652819Phase 3
- FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney DiseaseCompletedNCT02652806Phase 3